[OFER-TRABEC] NAC: Postdoctoral Beatriu Pin=?ISO-8859-1?Q?=C3=B3s?=

------------------------
¿Quieres coordinar una inciativa en el contexto academico?

RedIRIS te ofrece de forma gratuita una herramienta sencilla sin
conocimientos informáticos: Listas de distribución
http://www.rediris.es/list/crealist.html
*************************
(c)OFER-TRABEC es un servicio ofrecido por el Centro de Comunicaciones RedIRIS
(Permitida la reproducción siempre que se cite la fuente de este Servicio).
------------------------

---Procedencia:
Institución:IDIBELL
Contacto correo-e:mapujana@iconcologia.net
---
Postdoctoral Position in Biomedicine (Breast Cancer)

We seek for an excellent and highly motivated postdoc that is willing to apply for an AGAUR "Beatriu Pinós" (Generalitat de Catalunya) contract with our research group. The ideal candidate should be self-motivated and have strong academic training in biochemistry, genetics, and cancer cell biology. Applicants must have at least 2 years of postdoctoral training outside Spain and have first-authored publications in respected journals. The research group is situated within the Catalan Institute of Oncology (Bellvitge Institute for Biomedical Research, IDIBELL). The Institute offers strong interactive environment and various excellent opportunities for collaborative research exists within the institute and the surrounding Hospital area. Interested applicants are encouraged to apply with an email containing your curriculum vitae, and names and contact information of two references to Miguel Angel Pujana via email: mapujana@iconcologia.net.

----------------
Información complementaria de la oferta:
Recent publications by the group:
Maxwell et al. (2011). Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer. PLoS Biology Nov;9(11):e1001199.

Martrat et al. (2011). Exploring the link between MORF4L1 and risk of breast cancer. Breast Cancer Research 13(2):R40.

Aguilar et al. (2010). Biological reprogramming in acquired resistance to endocrine treatment of breast cancer. Oncogene 29(45):6071-83.

*************************************************************************
Para darse de baja OFER-TRABEC pinche y envíe:
mailto:OFER-TRABEC-signoff-request@listserv.rediris.es
*************************************************************************